Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Swift

Showing results (281-290 of 307) with videos related to

Pageof 31
Sort By:
Shock (Augusta, Ga.)|January 14, 2023
MYOSIN LIGHT CHAIN KINASE DELETION WORSENS LUNG PERMEABILITY AND INCREASES MORTALITY IN PNEUMONIA-INDUCED SEPSISDeena B Chihade, Prestina Smith, David A Swift, et al.
The Journal of Craniofacial Surgery|March 31, 2025
Evolution of Craniosynostosis Care at a Single Institution Over an 11-Year PeriodJohn B Phillips, Clay B Thames, Clarice A Swift, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|June 6, 2024
Implementation of an Enhanced Recovery After Surgery Protocol for Cranial Vault Remodeling ProceduresClarice A Swift, Colton J Fernstrum, Haven M Howell, et al.
The Journal of Craniofacial Surgery|May 13, 2025
The Impact of Tranexamic Acid Usage on Craniosynostosis Surgery Outcomes: A Single-Center ReviewAlexander E Velazquez, Anna G Boydstun, John M Sullivan, et al.
British Journal of Haematology|October 3, 2006
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm studyJames R Berenson, Ralph Boccia, David Siegel, et al.
The Lancet. Respiratory Medicine|November 20, 2021
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trialSeth Toback, Eva Galiza, Catherine Cosgrove, et al.
American Journal of Medical Genetics. Part A|April 27, 2004
Hypertelorism, ptosis, and myopia associated with drug-resistant epilepsy, mental delay, growth deficiency, ectodermal defects, and osteopeniaR Zannolli, S Buoni, F Macucci, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2017
Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatmentAleksandra P Vidisheva, James Wang, Tanya M Spektor, et al.
European Journal of Haematology|February 14, 2016
Risk of skin cancer in multiple myeloma patients: a retrospective cohort studyAustin A Robinson, James Wang, Suzie Vardanyan, et al.
American Journal of Hematology|December 2, 2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acidJames R Berenson, Ori Yellin, John Crowley, et al.
Pageof 31

Showing results (281-290 of 307) with videos related to

Sort By:
Pageof 31
Shock (Augusta, Ga.)|January 14, 2023
MYOSIN LIGHT CHAIN KINASE DELETION WORSENS LUNG PERMEABILITY AND INCREASES MORTALITY IN PNEUMONIA-INDUCED SEPSISDeena B Chihade, Prestina Smith, David A Swift, et al.
The Journal of Craniofacial Surgery|March 31, 2025
Evolution of Craniosynostosis Care at a Single Institution Over an 11-Year PeriodJohn B Phillips, Clay B Thames, Clarice A Swift, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|June 6, 2024
Implementation of an Enhanced Recovery After Surgery Protocol for Cranial Vault Remodeling ProceduresClarice A Swift, Colton J Fernstrum, Haven M Howell, et al.
The Journal of Craniofacial Surgery|May 13, 2025
The Impact of Tranexamic Acid Usage on Craniosynostosis Surgery Outcomes: A Single-Center ReviewAlexander E Velazquez, Anna G Boydstun, John M Sullivan, et al.
British Journal of Haematology|October 3, 2006
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm studyJames R Berenson, Ralph Boccia, David Siegel, et al.
The Lancet. Respiratory Medicine|November 20, 2021
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trialSeth Toback, Eva Galiza, Catherine Cosgrove, et al.
American Journal of Medical Genetics. Part A|April 27, 2004
Hypertelorism, ptosis, and myopia associated with drug-resistant epilepsy, mental delay, growth deficiency, ectodermal defects, and osteopeniaR Zannolli, S Buoni, F Macucci, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2017
Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatmentAleksandra P Vidisheva, James Wang, Tanya M Spektor, et al.
European Journal of Haematology|February 14, 2016
Risk of skin cancer in multiple myeloma patients: a retrospective cohort studyAustin A Robinson, James Wang, Suzie Vardanyan, et al.
American Journal of Hematology|December 2, 2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acidJames R Berenson, Ori Yellin, John Crowley, et al.
Pageof 31